aspirin has been researched along with Eosinophilic Esophagitis in 4 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Eosinophilic Esophagitis: Chronic ESOPHAGITIS characterized by esophageal mucosal EOSINOPHILIA. It is diagnosed when an increase in EOSINOPHILS are present over the entire esophagus. The reflux symptoms fail to respond to PROTON PUMP INHIBITORS treatment, unlike in GASTROESOPHAGEAL REFLUX DISEASE. The symptoms are associated with IgE-mediated hypersensitivity to food or inhalant allergens.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our data suggests that lymphocytic esophagitis is more likely to be found in older female patients and is significantly associated with achalasia, statin, and aspirin use." | 4.02 | Lymphocytic Esophagitis: Assessing Risk Factors and Clinical Outcomes. ( Bi, Y; Brahmbhatt, B; DeVault, KR; Ghoz, H; Krishna, M; Lacy, BE; Malviya, BJ; Palmer, WC; Zaver, HB, 2021) |
| "Endoscopic features of eosinophilic esophagitis (EoE) are variable with at least 2 phenotypes." | 1.43 | Impact of Diagnostic Delay and Other Risk Factors on Eosinophilic Esophagitis Phenotype and Esophageal Diameter. ( Kumar, A; Lipka, S; Richter, JE, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zaver, HB | 1 |
| Ghoz, H | 1 |
| Malviya, BJ | 1 |
| Brahmbhatt, B | 1 |
| Palmer, WC | 1 |
| Lacy, BE | 1 |
| DeVault, KR | 1 |
| Krishna, M | 1 |
| Bi, Y | 1 |
| Eid, RC | 1 |
| Palumbo, ML | 1 |
| Laidlaw, TM | 1 |
| Buchheit, KM | 1 |
| Cahill, KN | 1 |
| Lipka, S | 1 |
| Kumar, A | 1 |
| Richter, JE | 1 |
| Pelletier, T | 1 |
| Tamayev, R | 1 |
| Iammatteo, M | 1 |
| Nautsch, D | 1 |
| Hudes, G | 1 |
| Lukin, D | 1 |
| Jerschow, E | 1 |
4 other studies available for aspirin and Eosinophilic Esophagitis
| Article | Year |
|---|---|
Lymphocytic Esophagitis: Assessing Risk Factors and Clinical Outcomes.
Topics: Aged; Aspirin; Biopsy; Eosinophilic Esophagitis; Esophageal Achalasia; Esophagitis; Euterpe; Female; | 2021 |
A retrospective analysis of esophageal eosinophilia in patients with aspirin-exacerbated respiratory disease.
Topics: Aspirin; Asthma, Aspirin-Induced; Cyclooxygenase Inhibitors; Desensitization, Immunologic; Eosinophi | 2019 |
Impact of Diagnostic Delay and Other Risk Factors on Eosinophilic Esophagitis Phenotype and Esophageal Diameter.
Topics: Adult; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chi-Square Distribution; | 2016 |
Eosinophilic esophagitis as possible complication of aspirin treatment in patient with aspirin-exacerbated respiratory disease.
Topics: Adult; Aspirin; Asthma, Aspirin-Induced; Eosinophilic Esophagitis; Female; Humans; Nasal Polyps | 2017 |